Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 26 studies | 40% ± 16% | |
| astrocyte | 19 studies | 48% ± 18% | |
| oligodendrocyte | 15 studies | 47% ± 19% | |
| fibroblast | 13 studies | 39% ± 10% | |
| microglial cell | 12 studies | 30% ± 14% | |
| macrophage | 12 studies | 52% ± 24% | |
| smooth muscle cell | 10 studies | 34% ± 14% | |
| pericyte | 10 studies | 42% ± 12% | |
| adipocyte | 10 studies | 54% ± 19% | |
| glutamatergic neuron | 8 studies | 40% ± 20% | |
| GABAergic neuron | 7 studies | 45% ± 16% | |
| oligodendrocyte precursor cell | 7 studies | 29% ± 12% | |
| myeloid cell | 7 studies | 47% ± 18% | |
| endothelial cell of lymphatic vessel | 7 studies | 42% ± 13% | |
| capillary endothelial cell | 6 studies | 34% ± 18% | |
| mast cell | 6 studies | 31% ± 12% | |
| interneuron | 5 studies | 47% ± 24% | |
| cardiac muscle cell | 5 studies | 55% ± 14% | |
| type I pneumocyte | 5 studies | 47% ± 11% | |
| type II pneumocyte | 5 studies | 42% ± 13% | |
| neuron | 4 studies | 44% ± 20% | |
| dendritic cell | 4 studies | 26% ± 1% | |
| endothelial cell of artery | 4 studies | 23% ± 8% | |
| club cell | 4 studies | 25% ± 4% | |
| glial cell | 3 studies | 41% ± 24% | |
| vein endothelial cell | 3 studies | 29% ± 5% | |
| endothelial cell of vascular tree | 3 studies | 43% ± 10% | |
| cholangiocyte | 3 studies | 54% ± 14% | |
| hepatocyte | 3 studies | 69% ± 22% | |
| retinal pigment epithelial cell | 3 studies | 30% ± 14% | |
| connective tissue cell | 3 studies | 33% ± 12% | |
| epithelial cell | 3 studies | 30% ± 13% | |
| alveolar macrophage | 3 studies | 29% ± 10% | |
| monocyte | 3 studies | 23% ± 2% | |
| Schwann cell | 3 studies | 65% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 3249.52 | 459 / 459 | 99% | 13.48 | 1103 / 1118 |
| prostate | 100% | 2693.64 | 244 / 245 | 98% | 9.21 | 493 / 502 |
| stomach | 99% | 2635.40 | 357 / 359 | 98% | 10.24 | 279 / 286 |
| adrenal gland | 100% | 2798.36 | 258 / 258 | 97% | 11.00 | 223 / 230 |
| pancreas | 99% | 1502.41 | 324 / 328 | 97% | 9.38 | 173 / 178 |
| intestine | 100% | 5206.57 | 963 / 966 | 96% | 8.97 | 505 / 527 |
| thymus | 100% | 4533.09 | 653 / 653 | 94% | 12.62 | 570 / 605 |
| kidney | 100% | 1488.12 | 89 / 89 | 93% | 12.92 | 835 / 901 |
| lung | 100% | 3570.07 | 578 / 578 | 86% | 5.55 | 994 / 1155 |
| skin | 95% | 2301.64 | 1717 / 1809 | 91% | 14.55 | 429 / 472 |
| brain | 81% | 1169.82 | 2152 / 2642 | 99% | 8.25 | 696 / 705 |
| esophagus | 86% | 3304.55 | 1238 / 1445 | 92% | 8.69 | 168 / 183 |
| bladder | 100% | 3930.43 | 21 / 21 | 75% | 5.41 | 380 / 504 |
| ovary | 100% | 1736.44 | 180 / 180 | 75% | 3.47 | 324 / 430 |
| uterus | 99% | 3749.28 | 169 / 170 | 71% | 4.66 | 327 / 459 |
| liver | 89% | 860.71 | 202 / 226 | 81% | 4.79 | 329 / 406 |
| adipose | 100% | 3231.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.40 | 1 / 1 |
| blood vessel | 100% | 3651.06 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 99% | 1628.83 | 238 / 241 | 0% | 0 | 0 / 0 |
| heart | 98% | 2130.01 | 848 / 861 | 0% | 0 | 0 / 0 |
| muscle | 77% | 796.23 | 622 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 70% | 4.89 | 56 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 62% | 3.65 | 28 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 34% | 1.27 | 10 / 29 |
| peripheral blood | 17% | 383.03 | 160 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0090051 | Biological process | negative regulation of cell migration involved in sprouting angiogenesis |
| GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
| GO_0097498 | Biological process | endothelial tube lumen extension |
| GO_0030036 | Biological process | actin cytoskeleton organization |
| GO_0043542 | Biological process | endothelial cell migration |
| GO_0035023 | Biological process | regulation of Rho protein signal transduction |
| GO_0031966 | Cellular component | mitochondrial membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0005811 | Cellular component | lipid droplet |
| GO_0005515 | Molecular function | protein binding |
| GO_0008289 | Molecular function | lipid binding |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | STARD13 |
| Protein name | StAR related lipid transfer domain containing 13 StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein) (DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13) (StARD13) START domain containing 13, isoform CRA_b (cDNA, FLJ93332, Homo sapiens START domain containing 13 (STARD13), transcriptvariant gamma, mRNA) |
| Synonyms | DLC2 GT650 hCG_32808 |
| Description | FUNCTION: GTPase-activating protein for RhoA, and perhaps for Cdc42. May be involved in regulation of cytoskeletal reorganization, cell proliferation and cell motility. Acts a tumor suppressor in hepatocellular carcinoma cells. . |
| Accessions | H3BRG5 H3BUW7 ENST00000567873.2 ENST00000255486.8 [Q9Y3M8-2] Q9Y3M8 B2R789 ENST00000336934.10 [Q9Y3M8-1] ENST00000399365.7 [Q9Y3M8-3] ENST00000439831.1 |